Swiss stocks - Factors to watch on Dec 2

Calida Holding AG

02/12/2020 05:48

ZURICH/BERLIN, Dec 2 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Wednesday:
    
    CORONAVIRUS
    Asian shares rose after a strong lead from Wall Street
fuelled by hopes for additional U.S. economic stimulus and a
coronavirus vaccine, but trade was choppy as some investors
booked profits.  urn:newsml:reuters.com:*:nL4N2II173
    Top U.S. health officials announced plans to begin
vaccinating Americans against the coronavirus as early as
mid-December, as nationwide deaths hit the highest number for a
single day in six months.  urn:newsml:reuters.com:*:nL1N2IH34Y
    Germany reported a record number of daily COVID-19 deaths.
 urn:newsml:reuters.com:*:nL8N2II0CM
    
    
    SIX
    Trading turnover on the Swiss Stock Exchange rose 26.4% in
November compared to the previous month and reached 149.9
billion Swiss francs, SIX said. In the first 11 months, trading
turnover rose 19.6% to 1,633.7 billion francs.
    
    NESTLE  NESN.S 
    U.S. Supreme Court justices appeared wary of barring
lawsuits against American companies over alleged human rights
abuses abroad but signalled they could toss out a case accusing
Cargill and Nestle subsidiary of knowingly helping perpetuate
slavery at Ivory Coast cocoa farms.  urn:newsml:reuters.com:*:nL1N2IH17K
    
      
    COMPANY STATEMENTS
    * Roche's  ROG.S  Genentech said the U.S. FDA approved
Gavreto for people with certain types of thyroid cancers.
 urn:newsml:reuters.com:*:nBw6dfr5ta Additionally, Roche said announced that the FDA
approved Xolair for adults with nasal polyps.  urn:newsml:reuters.com:*:nGNE9yQf1P
    * Tecan  TECN.S : raises forecast for the full year of 2020
based on continued extraordinary demand for COVID-19 related
products; sales growth now expected to be in low to mid-teens
percentage range in local currencies; reported EBITDA margin now
forecast above 20.5% of sales  urn:newsml:reuters.com:*:nASN000L6F
    * Calida  CALN.S : holds 98% of Lafuma's  LAFU.PA  share
capital following its public tender offer; Lafuma's delisting to
take place on 4 December  urn:newsml:reuters.com:*:nFWN2IH0NG
    
    
    ECONOMY
    Swiss November CPI due at 0730 GMT. Seen -0.1% m/m, -0.5%
y/y.

 (Reporting by Zurich newsroom and Berlin Speed Desk)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
 
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German  .SDE 
All SMI constituent stocks  0#.SSMI 
DJ STOXX index  .STOXX 
Top 10 STOXX sectors  .PGL.STOXXS 
Top 10 EUROSTOXX sectors  .PGL.STOXXES 
Swiss mid-cap index  .SSMI 
Swiss all-share index  .SSHI 
Swiss market digest  .AD.S 
Sector overview  CH/SECTOR1 
All Swiss news  CH 
Swiss research news  CH-RCH   
All equity news  E 
SPEED GUIDES:   EQUITY   EQUITY/NEWS1   EUR/EQUITY   SWITZERLAND   REUTERS  ))